RedPath is a genomics-based cancer diagnostic company, providing comprehensive molecular analysis to resolve challenging diagnostics dilemmas.  RedPath’s patented PathFinder TG analysis couples traditional pathology practice with molecular genetic analysis providing a more complete picture and allowing physicians to make personalized, effective treatment decisions for their patients.